20-5302195-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PS1_ModerateBP4_Moderate
The NM_144773.4(PROKR2):c.1000G>A(p.Val334Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_144773.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROKR2 | NM_144773.4 | c.1000G>A | p.Val334Met | missense_variant | 3/3 | ENST00000678254.1 | NP_658986.1 | |
PROKR2 | XM_017027646.2 | c.1000G>A | p.Val334Met | missense_variant | 3/4 | XP_016883135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.1000G>A | p.Val334Met | missense_variant | 3/3 | NM_144773.4 | ENSP00000504128 | P1 | ||
PROKR2 | ENST00000217270.4 | c.1000G>A | p.Val334Met | missense_variant | 3/3 | 1 | ENSP00000217270 | P1 | ||
PROKR2 | ENST00000678059.1 | c.892G>A | p.Val298Met | missense_variant | 3/3 | ENSP00000503366 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251492Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135922
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727248
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 21, 2022 | Variant summary: PROKR2 c.1000G>A (p.Val334Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251492 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1000G>A has been reported in the literature in individuals with features of Kallman syndrome or idiopathic central hypogonadism (example, Sarfati_2013, Libri_2014). These report(s) do not provide unequivocal conclusions about association of the variant with Kallmann Syndrome 3. At least one publication reports experimental evidence evaluating an impact on protein function (example, Libri_2014). The most pronounced variant effect results in a functional score for this variant set to 50-70% WT activities. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 334 of the PROKR2 protein (p.Val334Met). This variant is present in population databases (rs371564610, gnomAD 0.02%). This missense change has been observed in individual(s) with Kallman syndrome (PMID: 24031091, 36138264, 36694982). ClinVar contains an entry for this variant (Variation ID: 1874771). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PROKR2 function (PMID: 24276467, 29161432). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at